Studies to date generally agree that CD8+ cytotoxic T lymphocytes (CTLs) and CD4+ Th1 cells are involved in effective anti-tumor immunity while FOXP3+ regulatory T cells are associated with suppression of anti-tumor immunity [7]. The gene discussed is CD8A; the disease is neoplasm.